MacroGenics Inc at Citi Biotech Conference Transcript
So we've -- this panel is called New Targets in Cancer Immunotherapy and the Tumor Microenvironment. Very pleased to have with us the Chief Executive Officers of 3 distinguished biotechs; Arcus' Terry Rosen; at CytomX over on the left Sean McCarthy, and of course, in the center, Dr. Scott Koenig at MacroGenics. So welcome all of you. And maybe just to kick off the discussion with sort of a broad-level question given the title of this session, talk about your approach to targeting the tumor microenvironment at a high level and maybe following on that just talk about what you believe is least appreciated by Wall Street and investors in your strategy and in your drug development pipeline. I am sure that will produce lots of interesting commentary. So, Terry, do you want to give it a...
Okay, sure. So in general, our approach, we don't discover targets, we tend to work where there has been a lot of biology done, but there may
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
